Anika Therapeutics, Inc. (ANIK) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $15.10 +3.28%
EPS Growth %: +115.4%
Financial Fact:
Cost of product revenue: 5M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +115.4%
Financial Fact:
Cost of product revenue: 5M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.51, $0.03 better than the analyst estimate of $0.48. Revenue for the quarter came in at $23.3 million versus the consensus estimate of $24.6 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Apple’s big price hike seen as "an unprecedented push to protect margins"
- Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
